Literature DB >> 34317720

Commentary: Cutaneous presentation of cardiac myxoma.

Rebecca M Gerlach1, Mark A Chaney2.   

Abstract

Entities:  

Year:  2020        PMID: 34317720      PMCID: PMC8288706          DOI: 10.1016/j.xjtc.2020.01.011

Source DB:  PubMed          Journal:  JTCVS Tech        ISSN: 2666-2507


× No keyword cloud information.
Rebecca M. Gerlach, MD, FRCPC Autoimmune-like skin changes caused by immunomodulatory cytokines may accompany a cardiac myxoma. See Article page 69. Diagnosing a cardiac myxoma can be challenging, because affected patients frequently present with nonspecific findings, such as fatigue, shortness of breath, or fever. The case report presented here serves as an important reminder to continue to seek alternative diagnoses in the setting of unexplained symptoms such as these. Ajira and associates from Japan present a unique narrative, describing an elderly female patient who initially reported fever, erythema of the legs, and skin changes that were resistant to conventional treatment, Blood tests produced negative culture results yet revealed a neutrophil-dominant leukocytosis and elevated interleukin 6. A skin biopsy revealed neutrophilic infiltration without evidence of vasculitis. Ajira and associates do not elucidate what led them to perform echocardiography; however, the transthoracic examination unexpectedly revealed a left atrial mass suggestive of a cardiac myxoma. After surgical removal, pathologic examination confirmed the diagnosis of myxoma. Further differentiation by immunostaining was positive for interleukin 6, interleukin 1β, and granulocyte colony-stimulating factor. After myxoma removal, the previous neutrophilic dermatosis and fever immediately resolved, and the patient remained free of symptoms at 65 months of follow-up. A cardiac myxoma may masquerade as an autoimmune disease through the secretion of immunoregulatory cytokines. Secretion of interleukin 6 by cardiac myxomas is a frequent finding, with higher levels correlated with increased tumor size, although this is not always associated with constitutional findings. Cytokine secretion can also lead to a host of paraneoplastic syndromes attributable to the cardiac myxoma, such as Raynaud's phenomenon, erythema and petechiae of hands and feet, leukocytosis, anemia, fever of unknown origin, acute renal failure, or peripheral demyelinating neuropathy. In this case, the neutrophilic dermatosis may have resulted from a common pathway of cytokines related to the cardiac myxoma. Neutrophil-mediated skin diseases are a group of disorders that include pyoderma gangrenosum and Sweet syndrome. As Ajira and associates point out, the rapid resolution of the patient's neutrophilic dermatosis and lack of recurrence support the conclusion that it was caused by cytokine release from the myxoma.
  4 in total

1.  Interleukin-6 plasma levels and tumor size in cardiac myxoma.

Authors:  R Soeparwata; P Poeml; C Schmid; H Neuhof; H H Scheld
Journal:  J Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 5.209

Review 2.  Cardiac myxoma induced paraneoplastic syndromes: a review of the literature.

Authors:  Marcus Smith; Muhammad A Chaudhry; Pedro Lozano; Mary Beth Humphrey
Journal:  Eur J Intern Med       Date:  2012-06-30       Impact factor: 4.487

Review 3.  Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases.

Authors:  Angelo V Marzano; Alex G Ortega-Loayza; Michael Heath; Daniel Morse; Giovanni Genovese; Massimo Cugno
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

4.  Granulocyte-colony stimulating factor- and interleukin-1β-positive cardiac myxoma accompanying neutrophilic dermatosis.

Authors:  Yoichi Ajiro; Hitoshi Nino; Takashi Ueda; Yukihiro Bonkohara
Journal:  JTCVS Tech       Date:  2020-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.